Top Investment Alerts

Expanding the AI Frontier: Fleet Meets NVIDIA NVIDIA just pulled a major move at their GTC Berlin event, rolling out a comprehensive suite of device management for their AI hardware ecosystem through Fleet. Picture this: IT folks can now handle NVIDIA’s flagship AI gear alongside all those pesky other devices without losing their minds or sleep. From RTX PRO...

Another Day, Another Court Battle Well, folks, if you thought corporate America was the only place where the numbers get wild, let me introduce you to Dean Tucci's latest legal nightmare. The man's up against a $43 million judgment from the Consumer Financial Protection Bureau (CFPB). For a business that did $2 million over three years? Yeah, you heard that right—sounds...

Broadridge's Big Day: Mark Your Calendars Well, it looks like Broadridge Financial Solutions is setting the stage for its financial theatrics on November 3rd, 2026. If you're in the game of stock trading, chalk this up as a must-watch event. These folks at NYSE:BR are opening the books for their first quarter of fiscal year 2027, and you'd want to be tuned in when Tim...

From Law Books to Power Lists Cue the applause, folks! Paige Kaplan Randolph has just snagged a shiny badge of honor being named to The Hollywood Reporter's Power Reps: Creators List for 2026. This ain't some random nod; it's a recognition spotlighting legal stalwarts shaping the ever-morphing mosaic of entertainment. If you're wondering where the real power behind the...

Drilling Deep: PMET's Quest for Mineral Riches You’d be hard-pressed to find another player pushing dirt as fervently as PMET Resources right now. They’ve got their hooks deep into Shaakichiuwaanaan in Quebec—and with over 30,000 meters of drilling chalked up from their elbow grease this year, you better believe it’s shaping up to be a geologist’s dream or a...

High Stakes for Chemours Shareholders Well, this isn’t your run-of-the-mill shareholder grumble. We're staring down an 18.63% plunge in Chemours’ stock—plenty to raise the eyebrows of anyone keeping tabs on this chemical giant. For those who snatched up Chemours shares between February 20 and August 4, 2026, the revelations about potential misstatements concerning...

Old School Meets New Tech: SQUID's 'Awardable' Moment In an era drowning in data, IESE Solutions throws us a lifeline with its SQUID platform—assessed 'Awardable' and now live on the Department of War's Chief Digital and Artificial Intelligence Office's (CDAO) Tradewinds Solutions Marketplace. Sounds technical, right? Well, let’s dive into why it matters for those...

Another Day, Another Leadership Shuffle at ATD Well, the wheel's turning again at American Tire Distributors (ATD). The crew in Huntersville, N.C., just put Michael Broderick in the driver's seat as Interim President, replacing Ira B. Silver. And they've parted ways with him—done and dusted. This isn't just some random pick; Broderick's been kickin' around ATD's Board...

Turbulence in the Satellite Markets When York Space Systems launched its flashy IPO earlier this year, investors lined up in droves, eyes gleaming at the promise of satellite-driven riches. But now, it feels like that promising start shattered faster than a cheap rocket. York, known for its bread-and-butter reliance on federal contracts, primarily with the U.S. Department...

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

Big Plans on the High Seas Here's another twist in the endless ocean of energy infrastructure milestones—Kinetics, the brainchild of Karpowership, is breaking ground, or rather, cutting steel in Singapore for its first high-capacity Floating Storage and Regasification Unit (FSRU). Just another day in the volatile world of LNG, right? This latest venture, tagged as LNGT...

Revance Therapeutics Faces Legal Scrutiny It has come to light that Revance Therapeutics, Inc. (NASDAQ: RVNC) is currently under investigation related to potential claims of securities fraud. This comes as a significant development for investors in the company who seek clarity and accountability in their financial dealings. Understanding the Investigation The...

Salarius Pharmaceuticals' Strategic Move Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a leader in biopharmaceutical development dedicated to providing innovative cancer therapies, has announced an important decision regarding its stock structure. The clinical-stage company is set to execute a 1-for-15 reverse stock split, effective shortly. This significant action...

The State of Civic Health in Maine Maine's civic health, despite the rising polarization in U.S. politics, stands resilient. A captivating new report by Colby College’s Goldfarb Center for Public Affairs uncovers insights into the civic engagement of its residents, calculated through various indicators. This comprehensive study, prepared alongside Public Engagement...

Palantir Technologies Achieves New Stock Highs Palantir Technologies Inc. shares, noted under the ticker PLTR, have recently reached impressive all-time highs due to a combination of remarkable company performance and growing market interest. Record-Breaking Earnings Report The catalyst for this surge was the company’s latest earnings announcement, which showcased a...